Skip to main content
DisclosureSome pages on this site contain affiliate links; we may earn a commission when you buy through them. Our scores and rankings follow our published methodology; commissions do not influence them. Read our methodology →
MushroomClinical dose · 1–1.8g/day in healthy-adult trials; 3g/day dry powder in the mild cognitive impairment trialOnset · Small acute effects within 1–2 hours in pilot trials; the MCI benefit built over 8–16 weeks

Lion's Mane

A 2009 double-blind, placebo-controlled trial (Mori et al., n=30) found higher cognitive function scores in adults with mild cognitive impairment after 16 weeks of 3g/day; scores fell again within 4 weeks of stopping. Its lead author works for Hokuto Corporation, a mushroom producer. A 2019 multicentre RCT improved MMSE scores but not the two other memory tests. In healthy adults, two small 2023 pilot RCTs found acute gains on Stroop, N-Back and reaction-time tasks at 1–1.8g, and only a non-significant trend toward lower stress after 28 days. The evidence is small-sample and short-term.

By The Nootropic Lab editorial teamUpdated 8 min read✓ Fact-checked

Evidence reviewed:

Mechanism of action

Lion's Mane (Hericium erinaceus) contains hericenones and erinacines that stimulate the synthesis of Nerve Growth Factor (NGF) in cell and animal studies. NGF promotes neuronal survival, differentiation, and maintenance of neurons in the hippocampus and cortex — regions central to learning and memory. No human trial has yet measured NGF levels after supplementation.

Clinical evidence summary

A 2009 double-blind, placebo-controlled trial (Mori et al., n=30) found higher cognitive function scores in adults with mild cognitive impairment after 16 weeks of 3g/day; scores fell again within 4 weeks of stopping. Its lead author works for Hokuto Corporation, a mushroom producer. A 2019 multicentre RCT improved MMSE scores but not the two other memory tests. In healthy adults, two small 2023 pilot RCTs found acute gains on Stroop, N-Back and reaction-time tasks at 1–1.8g, and only a non-significant trend toward lower stress after 28 days. The evidence is small-sample and short-term.

Human effect matrix

Based on human clinical trials only. Animal and in-vitro data excluded.

EffectEvidenceMagnitudeStudies
Memory & Learning moderate
Moderate
4
Mood & Stress preliminary
Negligible
1

Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results

Documented benefits

  • Higher cognitive scores in mild cognitive impairment (one 16-week RCT)
  • Small acute attention and reaction-time gains in healthy adults (pilot RCTs)
  • NGF stimulation (cell and animal studies only)

Side effects & cautions

  • Generally well tolerated; the 16-week MCI trial reported no adverse effects on laboratory tests
  • Rare: mild GI discomfort at high doses

How to take

Dosage1–1.8g/day (healthy-adult trials); the MCI trial used 3g/day of dry powder, so lower doses may not reproduce its result
TimingMorning, with breakfast
With foodFat-soluble compounds absorb better with a meal containing some fat. Taking on an empty stomach is fine but a meal improves consistency.
FormsCapsule or powder. Always choose fruiting body extract (hot-water or dual extracted), not mycelium-on-grain — mycelium products may be mostly starch with minimal active compounds.

Stacking recommendations

Ingredients that pair well with Lion's Mane and why.

Classic long-term memory stack. Bacopa consolidates memory via synaptic density; Lion's Mane supports NGF. Together they cover both neurogenesis and synaptic pathways.

Citicoline provides an acute focus effect while Lion's Mane builds long-term neuroprotection — a complementary short- and long-term pairing.

Ashwagandha reduces cortisol (which suppresses NGF expression); combining with Lion's Mane may amplify neurogenic effects under stress.

Frequently asked questions

Fruiting body vs mycelium — which should I buy?

Always choose fruiting body extract. Mycelium is grown on grain substrate and most commercial mycelium products contain primarily starch, not active hericenones. Look for "fruiting body" or "dual extract" on the label. Labels can differ by market: Mind Lab Pro's US label lists 500mg organic Lion's Mane "mycelium and fruit", while its EU, UK, Canadian and Australian labels list 500mg "fruiting body" (checked 2026-10-08).

How long before I notice results?

Two small 2023 pilot trials found modest acute effects on attention and reaction-time tasks 1–2 hours after a single 1–1.8g dose. The clearest result — in mild cognitive impairment — built over 8–16 weeks of 3g/day (Mori 2009) and faded within 4 weeks of stopping. Do not judge this supplement at 2 weeks.

Can I take Lion's Mane every day?

Daily use is how it was tested, but only for a limited time: daily dosing was used for up to 16 weeks in the MCI trial (Mori 2009), the other trials reviewed ran 12 weeks or less and the healthy-adult pilots 28 days or less, so longer-term controlled safety data are limited. Unlike some adaptogens, Lion's Mane is not cycled in the trials; the 16-week MCI trial used daily dosing and scores declined within 4 weeks of stopping, so any benefit appears to depend on continued use.

Does Lion's Mane interact with any medications?

None of the human trials reviewed reported drug interactions, but they were small and short. Always check with your doctor if you are on prescription drugs.

What does the research actually show for healthy adults?

Studies in healthy adults are small pilots. Docherty 2023 (n=41, 1.8g/day) found faster Stroop performance 60 minutes after a dose and only a non-significant trend toward lower stress after 28 days; La Monica 2023 found faster N-Back and Go reaction times 2 hours after 1g. Effects are subtler in healthy people than in mild cognitive impairment.

Top stacks containing Lion's Mane

Lion's Mane in Australia

Hericium erinaceus (lion's mane) does not appear in the current TGA Permissible Ingredients Determination (No. 2) 2026, whether searched under its botanical name, 'lion's mane' or 'yamabushitake' (checked 2026-10-08). The TGA states an ingredient absent from the Determination 'can't be used in listed or assessed listed medicines,' so a lion's mane product sold to an Australian buyer is not an AUST L listed medicine. Reviewed AU products on this site naming Lion's Mane as a hero ingredient (Mind Lab Pro, Hunter Focus) carry no AUST L number in this site's Australian catalogue, consistent with an ingredient outside the listed-medicines framework.

Why lion's mane can't carry an AUST L number

This site searched the full text of the current Determination (No. 2 2026, all six volumes as published on the Federal Register of Legislation) and found no entry for 'Hericium', 'erinaceus', 'lion's mane' or 'yamabushitake'. Per the TGA's guidance, 'if an ingredient isn't listed in the Determination, it can't be used in listed or assessed listed medicines,' so a sponsor cannot register an AUST L product with lion's mane as its active ingredient. A lion's mane product an Australian buyer can obtain has therefore not been through TGA listing; if it is imported personally, the TGA notes such imports 'are not evaluated by us, meaning their safety, quality and efficacy cannot be guaranteed.'

Products in Australia

TGA (AUST L)

Is lion's mane mushroom a TGA-listed medicine ingredient in Australia?

No. Hericium erinaceus (lion's mane) does not appear in the current Permissible Ingredients Determination (checked 2026-10-08), and the TGA states an ingredient absent from that list 'can't be used in listed or assessed listed medicines.' It cannot be the active ingredient in an AUST L listed product.

What does that mean for a lion's mane product I import myself?

The TGA's Personal Importation Scheme 'allows individuals to import therapeutic goods not entered in the Australian Register of Therapeutic Goods (ARTG), provided certain conditions are met,' but the TGA states such imports 'are not evaluated by us, meaning their safety, quality and efficacy cannot be guaranteed.'

Sources: TGA -- Permissible ingredients determination (overview) · Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 (F2026L00707), as compiled 17 September 2026 (Compilation No. 1, F2026C00940) -- Schedule 1 heading · TGA -- Personal Importation Scheme · TGA -- Personal Importation Scheme

Regulatory note

Therapeutic goods available in Australia are regulated by the Therapeutic Goods Administration (TGA). AUST L–listed products carry pre-approved permitted indications; AUST R–registered products are higher-evidence. Imported products without TGA listing are not assessed by Australian regulators. This page is editorial, not promotional, and does not constitute medical advice. Always read the label and follow directions for use. Consult a qualified healthcare professional before starting any supplement.

Sources (4)expand